Danlin Gu

Statistics

Publications

Citations

146

H-Index

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Danlin Gu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and potency optimization.

Publications per year

2005–2013

Publications

Cyclic urea derivatives as potent NK1 selective antagonists

Ho‐Jane Shue, Xiao Chen, Neng‐Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 47 citations

Medicine, Medicinal Chemistry, Pharmacology +4

Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitors

Rongze Kuang, Ho‐Jane Shue, David J. Blythin et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions

Ho‐Jane Shue, Xiao Chen, John H. Schwerdt et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +5

Discovery of oxazole-based PDE4 inhibitors with picomolar potency

Rongze Kuang, Ho‐Jane Shue, Li Xiao et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Discovery of oral and inhaled PDE4 inhibitors

Pauline C. Ting, Joe F. Lee, Rongze Kuang et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

1–5 of 5